View Full Paper

Student Name

Course

Date

Critical Evaluation of the HeLa Cell Data Agreement and Research Transparency

HeLa cells have been implicated in multiple cases of cell line misrepresentation and are a frequent source of infection of other cell lines. Research has demonstrated that the HeLa cell genome is extremely unstable and contains multiple genomic alterations, such as unusually high quantities of chromosomes, which is a condition known as chromothripsis (Britannica, 2022). In the article “Deal Done Over HeLa Cell Line,” Ewen Callaway discusses the HeLa data deal that followed the suit of Deborah Lacks seeking answers about HeLa cells. While the HeLa data deal allowed for the release of Deborah’s mother’s HeLa cell data report to the public, it is limited to the extent that it does not provide details of the HeLa cell genes collected from Henrietta Lacks or cover any other person’s or family’s HeLa genome details and data.

According to Callaway, a HeLa cell deal involved the Lacks family and the U.S. National Institutes of Health (NIH) following an NIH-funded project in which researchers were using Henrietta Lacks’ genes to study HeLa cells (2013). It was agreed among the parties involved that the family would not be compensated, but the data would be made available to the public with restricted access (Callaway, 2013). The article outlines that, following the collection of HeLa cell genes, it led to the growth of research and laboratory work involving HeLa cells. Collins, the director of NIH, noted that his laboratory was now growing HeLa cells and using them for all types of gene-expression experiments (Callaway, 2013). However, the article notes that there was no informed consent before the genes were collected. It also does not place significant emphasis on this matter, suggesting that it does not consider informed consent as a central aspect of the research.

In the article, Callaway (2013) did not provide the details of the experiment through which Henrietta Lacks’ data were collected and the cultivation of the cells began. Since the HeLa cell deal was based on results derived from Lacks’ genes, it was critical for the article to provide details of the genetic data, but it failed to make these data available, even though there was permission to make the data public. In addition, Callaway noted that the data could only be made available to the public through restricted access and that the agreement was a good solution (Callaway, 2013). However, it would be impractical and unusual to apply such an approach to other unconsented data and cell lines. The article is limited in its usefulness as a basis for future research by other researchers. In conclusion, the HeLa cell deal is practical in understanding the origins of HeLa cell genes and their relationship to human biological functioning.

Reference List

Britannica. (2022). HeLa cell. Britannica. Retrieved from https://www.britannica.com/science/HeLa-cell

Callaway, E. (2013). Deal done over HeLa cell line. Nature, 500(7461), 132–133.